At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,215 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Model-Observation Bridging Study (MOBS) for Ezetrol® and Inegy®
In Brief
An observational study for Dyslipidemia and Hypercholesterolemia. Completed, enrolled 3,215 participants.
Detailed Summary
This study is being done to provide valid data on the evolution of a cohort of French participants treated with ezetimibe, alone or in combination with a statin, to be used in simulation models for cardiovascular disease (CVD). Patterns of drug use, evolution of risk factors for CVD, cardiovascular morbidity and mortality, and goal attainment in low density lipoprotein cholesterol (LDL-C) levels over time will be analyzed.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDyslipidemia, Hypercholesterolemia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2008
First PostedAug 2011
Primary CompletionSep 2014
TodayJul 2026
First PostedAug 11, 2011
Enrollment StartNov 15, 2008
Primary CompletionSep 15, 2014
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 14.9 years ago